HALO logo
halo search icon
Telomir Pharmaceuticals, Inc.

US$1.31

Price Change Indicator
0.09 (7.38%)
Telomir Pharmaceuticals, Inc.
TELO · NAS

Telomir Pharmaceuticals, Inc.

Start Trading TELO for Free

US$1.31

Price Arrow0.09 (7.38%)
20/05/2026 04:00:00 PM
All-CompaniesHALO AllHALO Consensus Value
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Telomir Pharmaceuticals, Inc. Overview

TELO Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About TELO

icon

Website

Telomir Pharmaceuticals, Inc.

icon

Telephone

1.786.396.6723

icon

Address

Suite 2000-1009, 100 SE 2nd Street, Miami, FL 33131

Description

Telomir Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical company, which focuses on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells. The firm’s initial focus on treatments to inhibit the production of pro-inflammatory cytokines, such as IL-17, by oral administration of TELOMIR-1 as a therapeutic treatment for stem cells in situ. TELOMIR-1 is under investigation to provide a potential therapeutic intervention against age-related inflammatory conditions such as hemochromatosis, as well as for post-chemotherapy recovery, by interrupting and preventing the IL-17 induced inflammatory pathways that create the systemic imbalance of cellular metals. The company was founded by Christopher C. Chapman Jr. on August 26, 2021 and is headquartered in Miami, FL.

TELO Price Chart

Key Stats

Market Cap

US$83.91M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 1.05 - 3.1

Trade Value (12mth)

US$755,317.00

1 week

-3.17%

1 month

-12.23%

YTD

-8.96%

1 year

-42.72%

All time high

20.72

Key Fundamentals

EPS 3 yr Growth

1042.40%

EBITDA Margin

0.00%

Operating Cashflow

-$4m

Free Cash Flow Return

-112.50%

ROIC

-317.60%

Interest Coverage

0.00

Quick Ratio

5.10

Other Data

Shares Outstanding (Fully Diluted)

34m

HALO Sector

Healthcare

Next Company Report Date

03-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

TELO Announcements

Latest Announcements

DateAnnouncements
20 May 26
20 May 26
15 May 26
30 April 26
30 April 26

TELO Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-0.44-0.56-0.33locklocklock
EPS (Fully Diluted)
 $locklocklocklock-0.44-0.56-0.33locklocklock
Growth
 %locklocklocklock-1,433.0-26.841.2locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Telomir Pharmaceuticals, Inc. (TELO:NAS)?
Halo FAQ
The current share price of Telomir Pharmaceuticals, Inc. (TELO:NAS) is USD$1.31.
What is the 52-week high share price for Telomir Pharmaceuticals, Inc. (TELO:NAS)?
Halo FAQ
The 52-week high share price for Telomir Pharmaceuticals, Inc. (TELO:NAS) is USD$3.10.
What is the 52-week low share price for Telomir Pharmaceuticals, Inc. (TELO:NAS)?
Halo FAQ
The 52-week low share price for Telomir Pharmaceuticals, Inc. (TELO:NAS) is USD$1.05.
What is the dividend yield for Telomir Pharmaceuticals, Inc. (TELO:NAS)?
Halo FAQ
Telomir Pharmaceuticals, Inc. (TELO:NAS) does not pay a dividend.
What was Telomir Pharmaceuticals, Inc. (TELO:NAS) last dividend payment?
Halo FAQ
Telomir Pharmaceuticals, Inc. (TELO:NAS) does not pay a dividend.
What is the franking level for Telomir Pharmaceuticals, Inc. (TELO:NAS)?
Halo FAQ
Telomir Pharmaceuticals, Inc. (TELO:NAS) has a franking level of 0.00%.
In which sector is Telomir Pharmaceuticals, Inc. (TELO:NAS) classified?
Halo FAQ
Telomir Pharmaceuticals, Inc. (TELO:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial